149358 - INTEGRATE Study (An integrated general practice and pharmacy-based intervention to promote the prescription and use of appropriate preventive medications among individuals at high cardiovascular risk)
The INTEGRATE study aims to test the hypothesis that combining three evidence-based tools will increase the prescription and use of guideline-based medications, leading to improvements in cardiovascular disease (CVD) risk factors. The overall aim of this activity is therefore to · improve screening and management of cardiovascular disease in primary care.
Relevance to General Practice
Chronic cardiovascular disease (CVD) was present in approximately 3.5 million Australians in 2007-2008, accounted for 34% of premature deaths in 2008 and was estimated to cost 5.9 billion dollars in 2004-2005. Evidence shows that there continues to be a significant treatment gap in CVD risk assessment, the prescription and use of CVD preventive medications. Therefore, this study aims to combine a GP focus of improving risk assessment and guideline-based prescribing with HealthTracker tool, and promote medication adherence through both the polypill strategy and pharmacy-based adherence support program.
- To identify and overcome gaps in appropriate screening of people for cardiovascular risk.
- To identify and overcome gaps in adherence to best practice guidelines for the management of people identified at high cardiovascular risk.
- To identify barriers and enablers to the utilisation of secure electronic communication platforms to partner pharmacists to aid inter-professional collaboration
- GPs to implement a quality improvement approach to systems of care at their own general practices.